Works by Nogami, Yuka
Results: 9
Tirzepatide, a dual glucose‐dependent insulinotropic polypeptide/glucagon‐like peptide 1 receptor agonist, exhibits favourable effects on pancreatic β‐cells and hepatic steatosis in obese type 2 diabetic db/db mice.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 12, p. 5982, doi. 10.1111/dom.15972
- By:
- Publication type:
- Article
Dipeptidyl peptidase‐4 inhibitor and sodium‐glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high‐fat diet‐fed mice.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2339, doi. 10.1111/dom.15548
- By:
- Publication type:
- Article
Protective effects of the SGLT2 inhibitor luseogliflozin on pancreatic β‐cells in db/db mice: The earlier and longer, the better.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 10, p. 2442, doi. 10.1111/dom.13400
- By:
- Publication type:
- Article
Early combination therapy of empagliflozin and linagliptin exerts beneficial effects on pancreatic β cells in diabetic db/db mice.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-94896-w
- By:
- Publication type:
- Article
Decreased glucagon-like peptide 1 receptor expression in endothelial and smooth muscle cells in diabetic db/db mice: TCF7L2 is a possible regulator of the vascular glucagon-like peptide 1 receptor.
- Published in:
- Diabetes & Vascular Disease Research, 2017, v. 14, n. 6, p. 540, doi. 10.1177/1479164117725898
- By:
- Publication type:
- Article
Imeglimin exerts favorable effects on pancreatic β-cells by improving morphology in mitochondria and increasing the number of insulin granules.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-17657-3
- By:
- Publication type:
- Article
1435-P: Dulaglutide Exerts More Beneficial Antiatherosclerotic Effects in Early Phase of Diabetes than in Late Phase in ApoE Knockout Mice with Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1435-P
- By:
- Publication type:
- Article
2054-P: Combination of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor and Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor Substantially Protects Pancreatic ß-Cells Especially in Early Phase of Diabetes Rather than Advanced Phase.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-2054-P
- By:
- Publication type:
- Article
Protective effects of imeglimin on the development of atherosclerosis in ApoE KO mice treated with STZ.
- Published in:
- Cardiovascular Diabetology, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12933-024-02189-z
- By:
- Publication type:
- Article